LXRepair is a life science company that develops multiplexed high value functional tests to characterize cellular DNA Repair Enzymatic Activities. The objective of LXRepair is to design Companion Diagnostic kits with original DNA Repair biomarkers to help clinicians to optimize radiotherapy or chemotherapy treatments to fight cancer. Currently two preclinical studies are planned to identify chemoresistance and radioresistance biomarkers in metastatic melanoma and head and neck cancer, respectively.
LXRepair also proposes research tools for academic and industrial researchers allowing to identify DNA Repair based biomarkers in Pharma Drug Development, Cosmetic-Aging Sciences and Environmental and Industrial Toxicology.
LXRepair has a R&D Lab offering customized services on pre-clinical models (human and non-human) for biomarker identification.